Azacitidine, a therapeutic option in Lewis and Sumner syndrome associated with VEXAS syndrome

Rev Neurol (Paris). 2022 Dec;178(10):1109-1111. doi: 10.1016/j.neurol.2022.06.008. Epub 2022 Nov 8.

¹ Referral centre for neuromuscular diseases and ALS, APHM Marseille, La Timone Hospital, Marseille, France; Haematology and Cellular Therapy Department, La Conception, APHM, Marseille, France. Electronic address: thomas-escoda@hotmail.fr.
² Haematology and Cellular Therapy Department, La Conception, APHM, Marseille, France.
³ Referral centre for neuromuscular diseases and ALS, APHM Marseille, La Timone Hospital, Marseille, France.
⁴ Inserm, laboratoire d'hématologie, UMR9020-U1277 - Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, CHU de Lille, université de Lille, 59000 Lille, France.

No abstract available

Publication types